ImmunoGen Partners with Oxford BioTherapeutics to Develop Novel ADCs June 27, 2022 Auto Bot News 0 ImmunoGen has formed a research collaboration with Oxford BioTherapeutics to develop novel antibody-drug conjugates for cancers with high unmet needs.